Concord Medical Shares Outstanding vs. Price To Sales

CCM Stock  USD 5.09  0.16  3.25%   
Taking into consideration Concord Medical's profitability measurements, Concord Medical Services may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Concord Medical's ability to earn profits and add value for shareholders. As of the 2nd of December 2024, Price To Sales Ratio is likely to drop to 0.63. In addition to that, Days Sales Outstanding is likely to drop to 47.42. As of the 2nd of December 2024, Interest Income is likely to grow to about 18.1 M, though Accumulated Other Comprehensive Income is likely to grow to (62.1 M).
For Concord Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Concord Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Concord Medical Services utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Concord Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Concord Medical Services over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.97)
Revenue Per Share
107.978
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.04)
Return On Equity
(0.32)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Concord Medical Services Price To Sales vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Concord Medical's current stock value. Our valuation model uses many indicators to compare Concord Medical value to that of its competitors to determine the firm's financial worth.
Concord Medical Services is rated below average in shares outstanding category among its peers. It is rated below average in price to sales category among its peers . The ratio of Shares Outstanding to Price To Sales for Concord Medical Services is about  60,031,130 . At this time, Concord Medical's Price To Sales Ratio is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Concord Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Concord Price To Sales vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Concord Medical

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
2.82 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Concord Medical

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.05 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Concord Price To Sales Comparison

Concord Medical is currently under evaluation in price to sales category among its peers.

Concord Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Concord Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Concord Medical will eventually generate negative long term returns. The profitability progress is the general direction of Concord Medical's change in net profit over the period of time. It can combine multiple indicators of Concord Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-65.4 M-62.1 M
Income Tax Expense-24.6 M-23.3 M
Operating Income-463 M-439.8 M
Income Before Tax-555.6 M-527.8 M
Total Other Income Expense Net-92.6 M-88 M
Net Loss-440.7 M-418.7 M
Net Loss-531 M-504.5 M
Net Loss-531 M-504.5 M
Interest Income10.8 M18.1 M
Net Interest Income-154.8 M-147.1 M
Change To Netincome40.4 M31.6 M
Net Loss(68.14)(71.54)
Income Quality 0.52  0.49 
Net Income Per E B T 0.54  0.51 

Concord Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Concord Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Concord Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Concord Medical's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Concord Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Use Investing Themes to Complement your Concord Medical position

In addition to having Concord Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cleaning Thematic Idea Now

Cleaning
Cleaning Theme
Compnanies producing and distributing cleaning products, supplies, and accessories. The Cleaning theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cleaning Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Trending Equities.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
To fully project Concord Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Concord Medical Services at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Concord Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Concord Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Concord Medical investors may work on each financial statement separately, they are all related. The changes in Concord Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Concord Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.